Our strategy reduced the misdiagnosis rate to 2.11%, providing critical evidence for expert consensus towards the Healthy China Outline (2030). How about your other ‘firsts’ in cancer research?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback